Prognostic significance of plasma osteopontin in patients with locally advanced head and neck squamous cell carcinoma (HNSCC) treated with chemoradiation on TROG 02.02 phase III trial.
2011 ◽
Vol 29
(15_suppl)
◽
pp. 5506-5506
2011 ◽
Vol 18
(1)
◽
pp. 301-307
◽
2010 ◽
Vol 28
(15_suppl)
◽
pp. 5594-5594
Keyword(s):
2011 ◽
Vol 29
(15_suppl)
◽
pp. TPS196-TPS196
◽
Keyword(s):